The global pre-filled saline syringes market accounted to US$ 402.5 Mn in 2018 and is expected to grow at a CAGR of 7.2% during the forecast period 2019 – 2027, to account to US$ 744.4 Mn by 2027.
The pre-filled saline syringes market is highly competitive in nature with considerable number of players, having a high level of consolidation overall revenue share. Most of the companies operating in the pre-filled saline syringes market are present globally and have wide distribution and sales network through partnerships or authorized dealers.
The most notable pre-filled saline syringes market participants are BD, Cardinal Health, MedXL Inc., Guerbet Group, Sterisets Medical Products, DBM, B. Braun Medical Inc., Wolf Medical Inc., Aquabiliti and Baxter Healthcare Corporation, occupying a considerable share of the market owing to their offerings to the market.
Pre-filled saline syringes market leaders are involved in providing the products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. For instance, in November, 2017, Cardinal Health received 510 (k) FDA approval for Praxiject Saline prefilled syringes. It is available in variety of sizes; 3 ml, 5 ml, 10 ml and 20 ml.
Many well-known as well as small local companies are present in the market to provide diversified products to its customers. The larger firms are adopting the strategy of acquiring small firms to enhance its product portfolio and expand its footprint in different geographies. Additionally various companies are also undergoing other strategic alliances such as acquisitions and others to garner their significance and remain competitive in the pre-filled saline syringes market. Few on the important key developments from the industry are mentioned below:
|November, 2017||MedXL Inc. received 510 (k) FDA approval for Praxiject Prefilled syringes||North America|
|May, 2016||Cardinal Health received 510 (k) FDA approval for Monoject Prefill I.V. Flush Syringes||North America|
|April, 2016||Becton Dickinson to shutter Creedmoor, N.C. plant, which manufactures PosiFlush syringes and safety components, to lay off 120||North America|